Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
- PMID: 33406338
- DOI: 10.1056/NEJMc2032399
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
Comment in
-
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply.N Engl J Med. 2021 Jan 7;384(1):84-85. doi: 10.1056/NEJMc2032399. N Engl J Med. 2021. PMID: 33406339 No abstract available.
Comment on
-
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.N Engl J Med. 2020 Oct 1;383(14):1317-1327. doi: 10.1056/NEJMoa2019910. Epub 2020 Aug 29. N Engl J Med. 2020. PMID: 32865373 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources